KingMed Diagnostics announced that as of July 31, 2026, the company had repurchased 6.77 million shares, accounting for 1.46% of total share capital, with a total repurchase amount of 178 million yuan, at a price range of 23.36 yuan to 28.79 yuan per share. In the first quarter of 2026, the company achieved revenue of 1.351 billion yuan and net profit attributable to the parent company of 42.79 million yuan.
Guangzhou Kingmed Diagnostics Group Co LtdCompany repurchased 6.77 million shares for 178 million yuan, signaling confidence and supporting share price.